Suven Life Sciences Ltd. (SUVEN) Share Price Hits Fresh 52-Week High

Suven Life Sciences Ltd. Share Price rose 10.85% to Rs 368.35, hit a fresh 52-week high of Rs 374 and took market capitalisation to Rs 9,636.8 crore.

Suven Life Sciences Ltd. Share Price rose to Rs 368.35 on 20 August 2026, up Rs 36.05 or 10.85% from the previous close of Rs 332.3, after the stock touched a fresh 52-week high of Rs 374. With market capitalisation at Rs 9,636.8 crore and turnover at Rs 3.54 crore, the move has placed the stock firmly among the names drawing attention in Stock Market Today and Share Market Today discussions.

For investors tracking Suven Life Sciences Ltd. Share Price Today, the verified data confirms a sharp one-day move, a new yearly high and active trading participation. The supplied data establishes the price event clearly, but it does not establish a company-specific catalyst behind the rise. That distinction matters because a one-year high can reflect momentum, re-rating, or broader market positioning, yet only verified company data should be used to explain it.

From a Univest stock analysis perspective, the current setup is relevant for three reasons: the stock has broken into fresh 52 Week High territory, its valuation multiples can be compared with the broader Healthcare benchmark, and its profitability metrics present a more mixed Fundamental Analysis picture than the price move alone may suggest. Investors watching Suven Life Sciences Ltd. Stock News next will likely focus on whether price strength continues to stand alongside sector-relative valuation and return ratios.

Suven Life Sciences Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 368.35
Previous Close	Rs 332.3
Today's Change	+Rs 36.05 (+10.85%)
Day Open	Rs 337
Fresh 52-Week High	Rs 374
Day Low	Rs 335.45
Current Volume	96,056
Turnover	Rs 3.54 crore
Market Capitalisation	Rs 9,636.8 crore

Suven Life Sciences Ltd. (SUVEN) traded at Rs 368.35. versus the previous close of Rs 332.3, a rise of 10.85%. The stock opened at Rs 337, reached Rs 374, touched Rs 335.45. Reported volume was 96,056.

Suven Life Sciences Ltd. Share Price Today reflects a strong intraday surge, with the stock opening at Rs 337, moving to a day low of Rs 335.45, and then climbing to a fresh 52-week peak of Rs 374 before trading at Rs 368.35. The move from the previous close of Rs 332.3 translates into a gain of Rs 36.05 or 10.85%, highlighting a notable price expansion within a single session.

The day’s range also shows that buyers kept the stock above its opening level through most of the session. The difference between the day high of Rs 374 and day low of Rs 335.45 indicates a wide intraday spread, which often places a stock in Stocks in News and Market Movers screens. Even after easing from the day high, the stock remained materially above both the open and the previous close, which keeps the Suven Life Sciences Ltd. Share Price Update centred on upward price action rather than only a brief spike.

Turnover stood at Rs 3.54 crore, while current volume reached 96,056 shares. Together, these figures indicate that the breakout to a fresh 52-week high came with visible market participation rather than an isolated tick. In practical terms, the combination of a higher open than the previous close, a strong intraday push to Rs 374, and sustained trading near Rs 368.35 helps explain why Suven Life Sciences Ltd. Share News is being watched in today’s Market News cycle.

For readers searching Suven Life Sciences Ltd. Share Price Live or Suven Life Sciences Ltd. News Today, the clearest takeaway is straightforward: the stock registered a fresh one-year high and held most of its gains into the afternoon session. With that price event confirmed, the next step is to assess whether the broader financial profile supports continued investor attention.

Suven Life Sciences Ltd. (SUVEN) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 9,636.8 crore
P/E Ratio	48.9x
P/B Ratio	1.87x
ROE	-0.78%
ROCE	8.31%

Suven Life Sciences Ltd. was valued at a P/E ratio of 48.9x, a P/B ratio of 1.87x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	48.9x
Benchmark Median P/E	21.65x
Benchmark Average P/E	49.1x
Benchmark P/E Range	0x to 1,607.56x
Company P/B Ratio	1.87x
Benchmark Median P/B	1.9x
Company ROE	-0.78%
Benchmark Median ROE	11.09%
Company ROCE	8.31%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 9,636.8 crore
Benchmark Median Market Cap	Rs 135.91 crore

Suven Life Sciences Ltd. (SUVEN) is classified under sector: Healthcare.

Suven Life Sciences Ltd. (SUVEN) has a P/E ratio of 48.9x, which is above the benchmark median of 21.65x, a difference of +125.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Suven Life Sciences Ltd. (SUVEN) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Suven Life Sciences Ltd. (SUVEN) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ind-Swift Laboratories Ltd.	INDSWFTLAB	3,012.78	48.9	1.87	-0.78	8.31
Dishman Carbogen Amcis Ltd.	DCAL	2,648.85	167.12	0.41	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,610.72	64.32	10.17	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,569.06	33.71	6.95	36.29	42.4
Venus Remedies Ltd.	VENUSREM-BE	2,417.29	20.4	3.45	9.85	7.89

Suven Life Sciences Ltd. (SUVEN) has a P/E ratio of 48.9x compared with the displayed peer median of 48.9x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 9.85% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 8.31%, providing a capital-efficiency comparison. Suven Life Sciences Ltd. (SUVEN) has a market capitalisation of Rs 9,636.8 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Suven Life Sciences Ltd.

This stock is drawing attention because verified market data shows a meaningful price event, and the numbers allow investors to frame that move against valuation and sector context without relying on speculation.

• Fresh yearly high: Suven Life Sciences Ltd. Share Price hit Rs 374, marking a new 52-week peak.
• Strong one-day move: The stock rose Rs 36.05, or 10.85%, from the previous close of Rs 332.3 to Rs 368.35.
• Active participation: Volume reached 96,056 shares with turnover of Rs 3.54 crore.
• Large market-cap profile: Market capitalisation stands at Rs 9,636.8 crore, well above the supplied Healthcare benchmark median and average.
• Valuation context: P/E of 48.9 is above the sector median of 21.65 and near the sector average of 49.1, while P/B of 1.87 is slightly below the median of 1.9.
• Profitability watchpoint: ROE of -0.78% and ROCE of 8.31% remain below the Healthcare benchmark medians of 11.09% and 13.29%.

About Suven Life Sciences Ltd.

The supplied data identifies Suven Life Sciences Ltd. (SUVEN) as a Healthcare company. Beyond that sector classification, the verified dataset for this article is centred on market activity, valuation measures and sector benchmarking rather than detailed operating segments or product-level disclosures.

For readers following Suven Life Sciences Ltd. Latest News, the current market context is therefore built primarily around the stock’s fresh 52-week high, its Rs 9,636.8 crore market capitalisation, and how its P/E, P/B, ROE and ROCE compare with the wider Healthcare universe and the listed peer set. In that sense, the stock is being discussed today less for a supplied business update and more for a clear market event captured by the screener data.

On Univest, this kind of event-led coverage helps investors separate what is verified from what is not. The verified facts here are the one-year high, the day’s price and volume data, the current valuation ratios and the broader sector positioning available in the dataset.

Track Suven Life Sciences Ltd. Share Price on Univest

Use Suven Life Sciences Ltd. (SUVEN) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors using Univest can track Suven Life Sciences Ltd. Share Price through live market moves, 52-week levels, valuation ratios, peer snapshots and sector comparisons. For users following Suven Life Sciences Ltd. Share Price Today, Univest helps organise price action, market cap data, stock analysis inputs and broader market insights in one place.

That is especially useful on sessions like this, when Suven Life Sciences Ltd. Share Price reaches a fresh one-year high and becomes part of the day’s Stock Updates, Breakout Stocks and Momentum Stocks conversation. Instead of relying on unverified narratives, users can monitor the exact price move, turnover, peer positioning and benchmark comparisons through a structured data view on Univest.

Frequently Asked Questions

What is Suven Life Sciences Ltd. Share Price today?

Ans. Suven Life Sciences Ltd. Share Price was Rs 368.35 at the time of this update. The stock was up Rs 36.05 or 10.85% from the previous close of Rs 332.3 after touching a fresh 52-week high.

Why is Suven Life Sciences Ltd. Share Price rising today?

Ans. The verified data confirms that Suven Life Sciences Ltd. Share Price rose sharply and hit a fresh 52-week high of Rs 374. However, the supplied dataset does not establish any company-specific catalyst behind today’s 10.85% move.

What was the fresh 52-week high for Suven Life Sciences Ltd.?

Ans. Suven Life Sciences Ltd. Share Price touched a fresh 52-week high of Rs 374 in today’s session. The stock later traded at Rs 368.35, still materially above its previous close of Rs 332.3 and day open of Rs 337.

How much did Suven Life Sciences Ltd. gain today?

Ans. Suven Life Sciences Ltd. gained Rs 36.05 in absolute terms today, which translates into a 10.85% rise over the previous close of Rs 332.3. That move pushed the stock into fresh one-year high territory during the session.

What do today’s trading levels show for Suven Life Sciences Ltd.?

Ans. The stock opened at Rs 337, slipped to a day low of Rs 335.45, and then rallied to Rs 374 before trading at Rs 368.35. This wide intraday range shows strong upward price movement through the session.

What was the volume and turnover in Suven Life Sciences Ltd. today?

Ans. Suven Life Sciences Ltd. recorded current volume of 96,056 shares and turnover of Rs 3.54 crore in today’s trade. These figures show active participation alongside the stock’s rise to a fresh 52-week peak.

What is the market capitalisation of Suven Life Sciences Ltd.?

Ans. Suven Life Sciences Ltd. had a market capitalisation of Rs 9,636.8 crore in the supplied data. That is much higher than the Healthcare sector benchmark median of Rs 135.91 crore and average of Rs 467.67 crore.

How is Suven Life Sciences Ltd. valued versus the Healthcare sector?

Ans. The stock trades at a P/E of 48.9 against the sector median of 21.65 and average of 49.1. Its P/B is 1.87, slightly below the sector median of 1.9 and below the 2.6 average.

How do Suven Life Sciences Ltd. profitability ratios compare with the sector?

Ans. Suven Life Sciences Ltd. shows ROE of -0.78% and ROCE of 8.31%. Those figures are below the Healthcare benchmark median ROE of 11.09% and median ROCE of 13.29%, indicating weaker supplied profitability metrics than the broader sector.

How does Suven Life Sciences Ltd. compare with selected peers?

Ans. Suven Life Sciences Ltd. has the largest market cap in the supplied peer set at Rs 9,636.8 crore. Its P/E of 48.9 sits below Beta Drugs and Dishman Carbogen Amcis, but above Venus Remedies and Dr Agarwals Eye Hospital.